Rai et al. 2017 [20]
|
11
|
8 Melanoma, 1 HCC, 1 RCC, 1 BC
|
No pt. had loss in viral control or immune reconstitution inflammatory syndrome
|
2 CR, 1 PR, 4 SD, 4PD
|
Heppt et al. 2017 [19]
|
10
|
Melanoma
|
No increase in viral load, no effect on CD4 count
| |
Wightman et al. 2015 [18]
|
1
|
Melanoma
|
Improved CD4 count and decrease in Viral load
|
NA
|
Burke et al. 2011 [9]
|
1
|
Melanoma
|
Stable CD 4 count and viral load
|
PR
|
Morris et al. 2017 [14]
|
2
|
Anal cancer
|
Stable CD4 count and viral load
|
NA
|
Sandoval-Sus et al. 2017 [16]
|
1
|
Hodgkin lymphoma
|
Stable CD4 count and viral load
|
PR
|
Tomsitz et al. 2017 [17]
|
1
|
Melanoma
|
Stable CD4 count and viral load
|
PR
|
Ruzevick et al. 2013 [15]
|
1
|
Melanoma
|
Stable CD4 count and viral load
|
PR
|
Davar et al. 2015 [10]
|
1
|
Melanoma
|
Stable CD4 count and viral load
|
PD
|
Le Garff et al. 2017 [12]
|
1
|
NSCLC
|
CD4 count increased with stable viral load
|
PD
|
Guihot et al. 2017 [6]
|
1
|
NSCLC
|
Stable CD4 count and viral load
|
PR
|
Samri et al. 2017 [7]
|
12
|
NSCLC
|
Stable CD4 count and viral load
|
3 PR, 4 SD, 5 PD
|
Hentrich et al. 2017 [11]
|
1
|
NSCLC
|
CD4 count decreased but viral load remained stable
|
PD
|
McCullar et al. 2017 [13]
|
1
|
NSCLC
|
CD4 count decreased but viral load remained stable
|
CR
|
Uldrick et al. 2017 (NCT02595866)
|
17
|
Mix
|
Increase in CD4 count, viral load remained suppressed
|
NA
|